Syreon Corporation was established by Professor Paul Keown in 1995 in Vancouver, Canada, originally under the name “Synectics Corporation.” The term “synectics” derived from Greek, refers to the merging of unrelated elements and the creativity that emerges from collaboration across diverse fields. The company initially aimed to combine medical, pharmaceutical, statistical and information sciences to conduct international healthcare research.

By 2000, Synectics had rapidly expanded, partnering with a prestigious portfolio of global pharmaceutical corporations, biotechnology companies, and academic networks. As the name had already been registered in the USA, Synectics rebranded as Syreon (SYnectics REsearch ONline) to highlight its comprehensive electronic research solutions (Clinstream™). This method integrates clinical, laboratory, health outcomes, and economic data to evaluate treatment effectiveness and value. Today, although Syreon Corporation remains based in Vancouver, it conducts business in over 40 countries.

In 2008, Syreon Research Institute was officially established in Budapest by Zoltán Kaló, Zoltán Vokó, and Paul Keown, focusing on health economics, health policy, and pricing research. The Institute adopted the Syreon name due to its shared principles and commitment to supporting innovation in academic and public institutions, as well as multinational companies. What began as a small core team has grown into an independent international organization with over 50 colleagues collaborating with 150 partners, including major universities, public organizations, NGOs, and private companies worldwide.

Syreon Research Romania (SRR) was established in 2013.

The activity of the company in Romania is led by Dr. László Lorenzovici and is supported by a team of multidisciplinary specialists with extensive knowledge of the healthcare sector in Romania and other Central and Eastern European countries.

SRR carries out and coordinates a wide range of health economic analyses for acute and chronic diseases. Resource use is being monitored and data is collected from patients and healthcare providers as well as from analysts and consultants, in order to elaborate detailed and unique cost vectors for various disease indications. Also, medical outcomes are collected to measure the burden of disease, treatment consequences and cost-effectiveness of interventions.

SRR scientists have long-standing experience with the hospital and pharmaceutical industry, especially concerning developing and maintaining administrative healthcare databases.

Syreon Middle East (SME) was established in 2017.

The company located in Egypt is intended to provide expert services in the fields of health economics, market access, strategic pricing and corporate training for the pharmaceutical and health services sector in the Middle East region. Syreon Middle East was established in partnership with local experience to offer the best of both worlds, bringing the highest quality scientific research combined with local expert knowledge.

SME team has a long-standing experience in the pharmaceutical market in the Middle East.

Syreon Research Africa (SRA) was established in 2024.

Established in Accra, Ghana, SRA intends to serve the Sub-Sahara African region with high-quality, cutting-edge research, and capacity-building services in the fields of health economics, public health and public policy. Syreon Research Africa is a partnership which marries local expertise with the international research acumen of the Syreon brand.

For the past 3 years before incorporation, the SRA team has been actively involved in building partnerships with local governmental, non-governmental, and academic/research institutes, and capacity development endeavours.  

Syreon Research Africa aims to be the preferred research collaborator and partner towards advancing healthcare in Sub-Saharan Africa.